GSDMD and bronchopulmonary dysplasia: METTL3 aggravates pulmonary inflammation in bronchopulmonary dysplasia by mediating the m6A modification of ATG8, suppressing its expression, disrupting the GSDMD interaction, inhibiting autophagy, and inducing pyroptosis (30).